Randomized Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Colon Carcinoma Dukes C
A Prospectively Randomized Phase III Study on Adjuvant Chemotherapy and Adjuvant Chemo-Immunotherapy in Patients With Operated Colon Carcinoma Dukes C (Stage III; T1-4, N1-30, M0).
Sponsor: Austrian Breast & Colorectal Cancer Study Group
Listed as NCT00309530, this PHASE3 trial focuses on Colon Cancer Stage III and remains completed. Sponsored by Austrian Breast & Colorectal Cancer Study Group, it has been updated 5 times since 1990, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Change History
5 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2017 — Jan 2021 [monthly]
Completed PHASE3
First recorded
Oct 1990
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Austrian Breast & Colorectal Cancer Study Group
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Feldkirch, Austria, Graz, Austria, Güssing, Austria, Kirchdorf, Austria, Leoben, Austria, Linz, Austria, Oberpullendorf, Austria, Saint Veit A. D. Glan, Austria, Salzburg, Austria, Vienna, Austria and 4 more location s